Invention Grant
- Patent Title: Compositions including pafolacianine for the identification of malignant lesions
-
Application No.: US18111704Application Date: 2023-02-20
-
Publication No.: US11986540B2Publication Date: 2024-05-21
- Inventor: Sumith A. Kularatne
- Applicant: ON TARGET LABORATORIES, LLC.
- Applicant Address: US IN West Lafayette
- Assignee: ON TARGET LABORATORIES, LLC
- Current Assignee: ON TARGET LABORATORIES, LLC
- Current Assignee Address: US IN West Lafayette
- Agency: McAndrews, Held & Malloy, Ltd.
- Main IPC: A61B5/00
- IPC: A61B5/00 ; A61B8/00 ; A61B10/00 ; A61K49/00 ; A61P35/00
Abstract:
A composition is configured to be administered to a subject undergoing a malignant lesion resection procedure. The composition comprises a pharmaceutically effective amount of pafolacianine or a pharmaceutically acceptable salt thereof. The pafolacianine or a pharmaceutically acceptable salt thereof is configured to bind one or more malignant lesions and emit an optical signal.
Public/Granted literature
- US20230263911A1 COMPOSITIONS INCLUDING PAFOLACIANINE FOR THE IDENTIFICATION OF MALIGNANT LESIONS Public/Granted day:2023-08-24
Information query
